Earlier this week, we told you about Mark Lanier’s admittedly long-shot attempt to win the first trial of the 1,200 suits claiming that Pfizer’s epilepsy drug Neurontin increases suicide risk.

On Wednesday, the family of Susan Bulger, a 39-year-old who took Neurontin before hanging herself in 2004, dropped a suit against Pfizer after one full day of trial in Boston federal district court. Lanier, who had told us Bulger’s case was “near-impossible,” e-mailed to say that, after the first day of trial, an anonymous “friend of the family” heard how much money the plaintiffs planned to ask the jury for, and said that if Lanier spared Bulger’s 10-year-old daughter the ordeal of the trial, the friend would donate a substantial percentage of that amount to a trust established for the girl’s care and education.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]